Italy's antitrust regulator said on Thursday it had launched an investigation into pharmaceutical companies including Novartis (NOVN.S) and Roche-controlled (ROG.S) Genentech for having potentially restricted competition in the sale of an eye drug.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,